APPLICATION
NDA014601
TYPE
NDA
LATEST ACTION
1979-03-07
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
MEPROBAMATEDiscontinued
MEPROBAMATE 400MG · TABLET · ORAL
Approval history
1979-03-07Labeling · Supplement 27AP
1979-02-02Labeling · Supplement 26AP
1979-01-12Labeling · Supplement 25AP
1978-12-11Labeling · Supplement 24AP
1978-08-04Manufacturing (CMC) · Supplement 23 · standardAP
1978-04-04Labeling · Supplement 22AP
1977-06-27Labeling · Supplement 21AP
1977-06-06Labeling · Supplement 20AP
1977-05-25Labeling · Supplement 19AP
1975-02-21REMS · Supplement 15 · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.